Ledger.Open graph →
SEC Form D · Amendment · filed May 28, 2021

Oisin Biotechnologies, Inc

Offering
$9.5M
Sold
$9.5M
Exemption
Rule 506(b)
Industry
Other
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

John Lewis · Grand Cayman, Cayman IslandsExecEric Garcia · Seattle, WAExecSteve Hilbert · Seattle, WAExecMatthew Scholz · Seattle, WAExec · DirectorJohn Lewis · Cayman Islands, Cayman IslandsExecGary Hudson · London, United KingdomExec · DirectorDavid Gobel · Seattle, WADirectorJohn Lewis · Edmonton, Alberta, CanadaExecEric Garcia · San Francisco, CAExecSteve Hilbert · Seattle, WAExecGary Hudson · Seattle, WAExec · DirectorDavid Gobel · Seattle, WADirectorMatthew Scholz · Seattle, WAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗